Tumor stroma breaking system for efficient delivery of therapeutic agents
Ended Project Grant Awarded Last action
- Award ID
- R41CA247165
- Recipient
-
Migra-Therapeutics, LLC UEI NCN6HK3N2SG3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $330,363
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Atlanta, GA 30340, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $105,503 | |
| Original award | $224,860 |
Quick answers
Who received award R41CA247165?
R41CA247165 was awarded to Migra-Therapeutics, LLC by National Cancer Institute (National Institutes of Health) on June 23, 2020.
How much is award R41CA247165 worth?
$330,363 has been obligated on R41CA247165.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award